Recent Headlines
Assessment Shows Nation’s Guard is Down Against Zika Virus and Mosquito-Borne Diseases
The Council of State and Territorial Epidemiologists (CSTE) supports President Barack Obama’s request of $1.8 billion to combat Zika virus. Declared a “global health emergency” by the World Health Organization, Zika virus increasingly threatens to spread local epidemics in the... - February 08, 2016 - Council of State and Territorial Epidemiologists
Bioquark Inc. and Revita Life Sciences to Collaborate on Regenerative Medicine Applications in Spinal Cord Injury
Bioquark Inc., a cutting edge life sciences company focused on the development of a novel biologic portfolio of products, services, and technologies for complex regeneration, disease reversion, and aging in humans, is entering a collaboration with India's Revita Life Sciences to advance translational opportunities in spinal cord injury repair. - February 06, 2016 - Bioquark Inc.
Vivonics Sells Artificial Lung Technology
Vivonics, Inc. announced today the sale of intellectual property and other assets related to its Artificial Lung technology to Lung Biotechnology PBC, a wholly-owned subsidiary of United Therapeutics Corporation. Vivonics’ development of the Artificial Lung technology was supported by the... - February 04, 2016 - Vivonics, Inc.
Speaking of NEC Podcast Featuring Dr. Corrine Hanson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 02, 2016 - The Morgan Leary Vaughan Fund, Inc.
Genelex Receives Innovative Technology Designation from Vizient, Inc. for YouScript® Software
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript® software that reduces ER visits & hospitalizations with improved, gene-based medication management. Designation recognizes the development of new solutions that benefit the health care industry. - January 30, 2016 - Genelex Corp
ALPCO's New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time by Up to 86%
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step, allowing labs to improve sample processing time by up to 86%. - January 26, 2016 - ALPCO
MyTabib.com Connects You to Thousands of Medical Service Providers Worldwide
In January, a new medical portal MyTabib.com was launched providing a global healthcare search platform for patients. MyTabib.com offers patients the ability to search for clinics and doctors around the world in which they can compare cost procedures, book appointments right away, write comments and read real patient reviews in the comfort of their own home using the internet. - January 26, 2016 - MyTabib
Eagle Biosciences Announces the Launch of Functional Leptin ELISA
An Esoteric Kit for Measurement of Functional, Receptor Binding Leptin Levels in Serum or Plasma - January 25, 2016 - Eagle Biosciences, Inc.
Children’s Healthcare of Atlanta Received $1M Research Grant from Enduring Hearts
Children’s Healthcare of Atlanta has received a generous grant of $1,000,000 from the Enduring Hearts Foundation to fund cardiac research to enhance the lives of children needing heart transplantation. Some of the research funded will be that of Michael Davis, Ph.D., Director of the... - January 22, 2016 - Enduring Hearts
Asian Patent Acceptances Enhance Braasch Biotech Livestock Portfolio
New paradigm of using vaccines to enhance productivity in livestock, Braasch Biotech continues portfolio expansion - January 21, 2016 - Braasch Biotech LLC
International Society on Thrombosis and Haemostasis Releases New Clinical Core Curriculum to Aid Specialization of the Field
Journal of Thrombosis and Haemostasis publishes article on first internationally developed and reviewed Core Curriculum to guide clinical knowledge and training in the industry - January 21, 2016 - International Society on Thrombosis and Haemostasis (ISTH)
Microbiome Therapeutics Market: What’s the Future Potential?
The "Microbiome Therapeutics Market, 2015-2030" report provides a comprehensive study on the current landscape and the future outlook of the evolving pipeline of products in this area. - January 18, 2016 - Roots Analysis
NanoHybrids Receives Grant Funding to Develop Breakthrough Technology in Cancer Detection and Diagnosis
NanoHybrids receives $225,000 from the National Cancer Institute (NCI) to develop breakthrough immunohistochemistry (IHC) technology. - January 10, 2016 - NanoHybrids
Now More Hope for Menopausal Women Experiencing the Physical and Emotional Impact of Painful Sex and Vaginal Dryness
New clinical data released on Prasterone (DHEA) Vaginal Ovules' positive effect on moderate to severe dyspareunia (Painful sex due to menopause) and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. - January 06, 2016 - Endoceutics
Speaking of NEC Podcast Featuring Dr. Sergio Golombek Recently Launches
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - January 01, 2016 - The Morgan Leary Vaughan Fund, Inc.
RFID and Enhanced UDI Tracking Updates Announced by Matrix IT, Medical Tracking Systems
Matrix IT, Medical Tracking Systems has announced the addition of RFID data capture and product enhancements to TRACTUS, the world's first sterile field UDI scanning and compliance platform. The platform now also integrates with any health or inventory management system in a hospital. - December 30, 2015 - Matrix Medical Tracking Systems
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
Hemophilia Treatment ACE910 Bypasses Factor VIII Inhibitor in Affinity Biologicals Plasmas
Chugai Pharmaceutical's newly developed antibody ACE910 is a potential lifesaving treatment for Hemophilia A patients who have developed Factor VIII inhibitors. A first-in-human study (1) recently published by the American Society of Hematology indicates that ACE910 may be a safe and effective treatment for hemophilia A patients. - December 11, 2015 - Affinity Biologicals
Research Square Announces Video Summaries Solution to Help Researchers Communicate Their Work More Effectively
Research Square is partnering with MyScienceWork to offer engaging Video Summaries of research through the Polaris platform for universities and institutions. - December 11, 2015 - Research Square
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
Product Spotlight: Introducing Factor V Coagulation Antibodies from Affinity Biologicals Inc.
The human heart is an amazing vessel that pumps blood throughout the body, but sometimes genetic mutations make it difficult for the cardiovascular system to function the way it should. Most people inherit the factor V protein gene, which promotes healthy blood clotting throughout the body. Unfortunately, some inherit the factor V Leiden gene, which does just the opposite and prevents blood from clotting normally. - November 30, 2015 - Affinity Biologicals
Dr. Sebag Brings the Floaters Discussion to Paris; Dr. Sebag Presents VMR's Floater Program Findings to the French Ophthalmology Society’s Annual Meeting in Paris, France
Dr. Sebag presented VMR's floater program findings at the French Ophthalmology Society’s annual meeting in Paris. He described curing floaters with a limited vitrectomy where only the offending vitreous tissue opacities are removed, as opposed to the entire vitreous. This outpatient operation is performed in just 10 minutes, without sutures, under local anesthesia. The effectiveness of this surgery has been published in worldwide and patients are increasingly requesting the treatment. - November 26, 2015 - VMR Institute
Aurora Scientific Inc. Unveils New Brand and Celebrates the Official Opening of a New Manufacturing Facility
On October 8, 2015, Aurora Scientific, a science and technology firm in Aurora, ON welcomed guests to celebrate the official launch of their new brand and grand opening of their new manufacturing facility. The event brought together local suppliers and dignitaries, valued clients, families and friends, marking a milestone for the growing company. - November 21, 2015 - Aurora Scientific Inc.
Monica Monici, the Scientific Director of ASAlaser Scientific Research Department, was Elected ELGRA President
Dr Monica Monici was appointed to a high office in the non-profit International Scientific Society devoted to the promotion of scientific research under various gravity conditions. - November 19, 2015 - ASA srl
Mercy Receives FDA Award for Medical Device Tracking
Collaborative agreement could be worth up to $5.2 million over three years. - November 18, 2015 - Mercy
EternoGen Aesthetics Completes Its Financing Round Securing $5MM to Commercialize Their First in Class Bio-Dermal Restoration Portfolio
EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of... - November 18, 2015 - EternoGen Aesthetics LLC
ReproTech Staff Discuss Fertility Preservation Options for Oncology Patients in Ft. Worth, TX
Cancer Care Services in Fort Worth, TX was the setting for a presentation entitled Fertility Preservation for the Oncology Patient. This program strives to promote education and extend access to fertility preservation services. - November 18, 2015 - ReproTech, LLC
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
Zenalux Announces Grants from the National Institute of Health for Cancer Screening
Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, has been awarded a grant from the National Institute of Health (NIH) to further develop the Zenascope® to screen for cancer by employing imaging and reducing operator error. Zenalux is also participating in an Academic Industry... - November 06, 2015 - Zenalux Biomedical, Inc.
FastQS Announces Launch of Complaint Management Solution for Medical Device Companies
FastQS, today, announced the launch of its modern cloud-based Complaint Management Solution designed specifically for the medical device industry. With FastQS, medical device companies can easily process complaints paperlessly and compliantly. Robust complaint management is a requirement under the... - November 05, 2015 - FastQS
Salotex Has Reduced Its Services Offered
Salotex has made the decision to reduce its list of services and focus on 3 core services. Custom hearing protection, for both work and play, audiometric (hearing) testing and drug & alcohol testing. - November 05, 2015 - Salotex Health
PBTF, ABC2 Cofund Pediatric Brain Cancer Screening Research
The Pediatric Brain Tumor Foundation and ABC2 (Accelerate Brain Cancer Cure) are working together to fund the development of immunosignature-based blood tests for detecting, classifying and monitoring pediatric medulloblastoma over time. - November 04, 2015 - Pediatric Brain Tumor Foundation
DNAe Secures £25 Million ($38 Million) Bank Facility to Fund Development of Pioneering Point-of-Need IVD for Serious Blood Infections
DNAe, the inventors of semiconductor DNA sequencing technology, have secured a bank facility of £25 million ($38 million) to fund the final development stages of DNAe Diagnostics’ revolutionary point-of-need test for serious blood infections. This will include clinical trials targeted for 2016 and product launch in 2017. - November 04, 2015 - DNA Electronics
The Scientific Journal Highlights ASAlaser’s Commitment in Research
The company from Vicenza, leader in the study and implementation of laser’s therapeutic solutions, celebrates the first 7 years of Energy for Health, a magazine devoted to physical therapy. - November 01, 2015 - ASA srl
Speaking of NEC Podcast Featuring Dr. Sheila Gephart Launches October 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts—neonatologists, clinicians and researchers—that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - October 26, 2015 - The Morgan Leary Vaughan Fund, Inc.
Clinical Trials in Russia. The Third Quarter 2015.
The Ministry of Health of the Russian Federation approved 203 new clinical trials of all types, including local and bioequivalence studies, during the 3rd Quarter of 2015. This represents a 13% increase over the same period of last year. - October 25, 2015 - Synergy Research Group
T-Cell Immunotherapy Market to be Worth USD 30 Billion by 2030, Predicts Roots Analysis
The “T-Cell Immunotherapy Market, 2015-2030” report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the market segmented into the following three sub-groups: CAR-T therapies, TCR therapies and TIL therapies. - October 13, 2015 - Roots Analysis
ASAlaser Launches ASAveterinary APP
This application dedicated to the use of MLS® Laser therapy in the vet sector was created as a result of the technological research carried out by the company that leads the production of laser therapy solutions. This useful instrument, which is ready to use, is perfect for sector professionals. - October 10, 2015 - ASA srl
Matrix Medical to Unveil Enhanced TRACTUS Platform at NASS 2015
Matrix IT Medical Tracking Systems LLC has announced plans to release and demonstrate the newest version of TRACTUS. This is the world's first sterile field scanner and aids in stakeholder compliance to the FDA's UDI Final Rule. - October 07, 2015 - Matrix Medical Tracking Systems
New Research Identifies Leading Clinical CROs Best Positioned for Future Success
New Research Identifies Future Leadership and Benchmarks CRO Operational Performance with over 160 Clinical Outsourcing Decision Makers - October 07, 2015 - Life Science Strategy Group, LLC
Northern California Motorcyclists Ride for Kids with Brain Tumors
Nearly 200 motorcyclists gathered for the Northern California Ride for Kids over the weekend to support children battling brain tumors. As of ride time, the family-friendly motorcycle event in Fairfield, Calif., had raised $59,342 to support the Pediatric Brain Tumor Foundation. The event honored... - October 07, 2015 - Pediatric Brain Tumor Foundation
Mercy Opens World’s First Virtual Care Center
Described as a “hospital without beds,” center uses technology to care for patients. - October 06, 2015 - Mercy
ELISA Biology Contract Research Services Provided by Altogen Labs
Enzyme Linked Immunosorbent Assay (ELISA) is a widely used laboratory research assay designed for detecting and quantifying substances such as peptides, proteins, antibodies and hormones. ELISA is a very accurate, highly sensitive and specific immunoassay in comparison to other types of common... - October 03, 2015 - Altogen Labs
Regulate Gene Expression with Altogen Labs RNAi Technology
Ribonucleic Acid or RNA is a molecule critical to biology because it is behind the coding, regulation and expression of genes. With the RNA Interference or RNAi technology service offered by Altogen Labs it is possible to effectively regulate gene expression. Moreover, Altogen Labs has developed... - October 03, 2015 - Altogen Labs
Bostonians Walk, Run for Kids with Brain Tumors
About 200 Bostonians gathered on Sept. 26 for the Starry Night Boston 8.5K, benefiting the Pediatric Brain Tumor Foundation. At start time, the event had raised $27,074 to help fund the foundation’s lifesaving research and life-changing family support programs. The crowd gathered for the... - September 30, 2015 - Pediatric Brain Tumor Foundation
Motorcyclists Contribute $167,000 to Aid Sick Children
From the Las Vegas Strip to the Capitol area, more than 700 motorcyclists gathered for children battling brain tumors over the weekend. As of ride time, the family-friendly Baltimore-Washington and Las Vegas Ride for Kids events had raised $167,459 to support the Pediatric Brain Tumor... - September 30, 2015 - Pediatric Brain Tumor Foundation
Speaking of NEC Podcast Featuring The NEC Society Launches September 28
Episode 7 features Jennifer Canvasser, Founder of the NEC Society, and Dr. Samir Gadepalli, NEC Society scientific advisory council member. In 2014, Jennifer founded the NEC Society, a non-profit organization dedicated to protecting fragile infants, after losing her son, Micah, to Necrotizing Enterocolitis. - September 24, 2015 - The Morgan Leary Vaughan Fund, Inc.
L-Mesitran's Soft is Effective in the Treatment of Ear Infections in Dogs
L-Mesitran Soft is effective when treating ear infections in dogs, even antibiotic resistant bacteria are effectively killed. It is also effective in the restoration of wounds and bacterial infections. Using medical grade honey reduces the use of antibiotics and prevents resistance. It is a good... - September 24, 2015 - Mesitran